Katsuhisa Nakatsuka - Publications

Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression.

Journal: PloS one

Published: June 21, 2018

Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 18, 2018

Epigastric pain syndrome accompanying pancreatic enzyme abnormalities was overlapped with early chronic pancreatitis using endosonography.

Journal: Journal of clinical biochemistry and nutrition

Published: April 30, 2017

Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 29, 2015

Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance.

Journal: World journal of hepatology

Published: April 27, 2015

Safety and efficacy of partial splenic embolization in telaprevir-based triple therapy for chronic hepatitis C.

Journal: Internal medicine (Tokyo, Japan)

Published: March 07, 2015

Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients.

Journal: BMC infectious diseases

Published: January 17, 2015

Relationship between HCV dynamics and sustained virological responses in chronic hepatitis C genotype 1b patients treated with telaprevir-based triple therapy.

Journal: European journal of gastroenterology & hepatology

Published: October 31, 2014

Effect of fluvastatin on 24-week telaprevir-based combination therapy for hepatitis C virus genotype 1b-infected chronic hepatitis C.

Journal: European journal of gastroenterology & hepatology

Published: April 16, 2014

Serum 25-hydroxyvitamin D3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: October 11, 2013

Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study.

Journal: Hepatitis monthly

Published: September 15, 2013

Effects of fasudil on the portal and systemic hemodynamics of patients with cirrhosis.

Journal: Journal of gastroenterology and hepatology

Published: August 02, 2013